Total Reports
97
FDA CVM filings
Fish /
FDA CVM · 2025 release 97 reports on file
Atlantic Salmon (Salmo salar) - FDA Adverse Event Profile
Adverse-event records for Atlantic Salmon (Salmo salar) (Fish) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among fish breeds, Atlantic Salmon (Salmo salar) is #232 by FDA report volume; 99.0% of its 97 reports (96) were death-coded.
- #232
- most-reported fish breed
- 99.0%
- death-coded report share
- 69
- Death - top reaction
- 0.7 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
96
of 97 reports
Death Rate
99.0%
death-coded share
Avg Age at Report
0.7 yr
0.4 kg avg weight
Death-Coded Outcome Share
Atlantic Salmon (Salmo salar) death-coded reports 99.0%
Cross-breed median
99.0% of 97 atlantic salmon (salmo salar) reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 0.4 kg (0.9 lbs)
Top Reported Reactions
Death 69
IGA Animal mortality greater than expected 41
Fish body deformity 31
Moribund 24
IGA Animal morbidity greater than expected 17
Most Referenced Drugs
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) 88
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage 7
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) 1
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The Alocus In The Eo-1A Lineage) 1
Outcome Breakdown
Died
69 (60.0%)
Euthanized
42 (36.5%)
Ongoing
4 (3.5%)
Gender Distribution
Female 93 (95.9%)
Unknown 4 (4.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2015 | 2 | |
| 2016 | 16 | |
| 2017 | 12 | |
| 2018 | 7 | |
| 2019 | 10 | |
| 2020 | 16 | |
| 2021 | 14 | |
| 2022 | 9 | |
| 2023 | 10 | |
| 2024 | 1 | |
Atlantic Salmon (Salmo salar) Pet Health Insights
Atlantic Salmon (Salmo salar) accounts for 97 FDA adverse event reports, ranking #232 by volume among fish breeds, with 96 reports (99.0%) coded as a death outcome. Mean age at report: 0.7 years, average weight 0.4 kg (0.9 lbs).
Top reported signs: Death (69), IGA Animal mortality greater than expected (41), Fish body deformity (31). Most-referenced drug: Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) (88 reports), followed by Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage (7) and Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) (1).
Outcome coding on 115 status-recorded reports is dominated by Died (60.0%). Annual submissions ranged 2,015-2,024 across 10 years on file.
Fish Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Atlantic Salmon (Salmo salar)? ▼
There are 97 adverse event reports involving Atlantic Salmon (Salmo salar) in the FDA database, with 96 reports involving death (99.0% death rate). Atlantic Salmon (Salmo salar) ranks #232 by report volume.
What are the most common adverse reactions reported for Atlantic Salmon (Salmo salar)? ▼
The most commonly reported adverse reactions for Atlantic Salmon (Salmo salar) are Death (69 reports), IGA Animal mortality greater than expected (41 reports), Fish body deformity (31 reports), Moribund (24 reports), IGA Animal morbidity greater than expected (17 reports).
What drugs are most frequently associated with Atlantic Salmon (Salmo salar) adverse events? ▼
The drugs most frequently referenced in Atlantic Salmon (Salmo salar) adverse event reports are Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) (88 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage (7 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) (1 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The Alocus In The Eo-1A Lineage) (1 reports).
What is the average age of Atlantic Salmon (Salmo salar) in adverse event reports? ▼
The average age of Atlantic Salmon (Salmo salar) at the time of adverse event reports is 0.7 years, with an average weight of 0.4 kg (0.9 lbs).
Does a high number of adverse event reports mean Atlantic Salmon (Salmo salar) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Atlantic Salmon (Salmo salar) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.